Asia-Pacific clinical trial services market is expected to grow at a CAGR of 9.08% from 2020-2026
Geographically, the Asia-Pacificclinical trial services market is bifurcated into China, Japan, India, Australia, Thailand, Singapore, Indonesia, Rest of Asia-Pacific. Followed by Australia, Singapore, China and India is the fastest-growing market and is estimated to dominating the market across the region during the forecast period of 2020-2026.